// App-Quantinova.ai

e20058 : The impact of induction chemoimmunotherapy (iCIT) on the immune status of patients (pts.) with non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Elena Yurievna Zlatnik

Principal Investigators

  • Oleg Ivanovich Kit

  • Igor N. Turkin

  • Yury N. Lazutin

  • Anna Pavlovna Kharitonova

  • Inna Arnoldovna Novikova

  • Gennadiy Z. Sergostyants

  • Liubov Yu Vladimirova

  • Galina I. Zakora

  • Olesya N. Selyutina

  • Elena Bondarenko

  • Sergey P. Pyltsin

  • Anna V. Chubaryan

  • Tamara G. Ayrapetova

  • Pavel A. Anistratov

  • Igor A. Leyman

  • Rukiyat Isaeva

Medical Centers

  • Rostov Research Institute of Oncology, Rostov-on-Don, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Fc gamma RIIIa

Drug/Treatment

  • Gemcitabine

  • Cisplatin

  • Refnot

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved